ISouth Africa Delivery, iDaily Domestic Delivery, I-European Domestic Delivery

I-Abiraterone (154229-19-3)

Akukho kalo
5.00 ngaphandle kwe 5 ngenxa ye 1 ireyithingi abathengi
SKU: 154229-19-3. Udidi:

I-AASraw ine-synthesis kunye nobuchule bokuvelisa ukusuka kwigram ukuya kwi-odolo ye-Abiraterone (154229-19-3), phantsi kommiselo weCGMP kunye nenkqubo yolawulo lomgangatho olandelwayo.

Ingcaciso yeMveliso

Ividiyo ka-Abiraterone (154229-19-3) ividiyo


I-Abiraterone (154229-19-3) Sukufunyanwa:

Ulwakhiwo lweKhemikhali: Igama lemveliso: Abiraterone
Thenga i-Abiraterone (154229-19-3) hplc≥98% | Abathengisi beAASraw Cas No.: 154229-19-3
I-Molecular Formula: C24H31NO
Isisindo somzimba: 349.5
Iintetho: Abiraterone

154229-19-3

17- (3-Pyridyl) androsta-5,16-dien-3beta-ol

I-CB 7598

CB-7598

Ukugcina: Emile, emnyama
Amaxwebhu (COA & HPLC njl.njl): iyafumaneka

Abiraterone (154229-19-3) Dkubhala:

I-Abiraterone powder, ekwabizwa ngokuba yi-CB7598, yi-metabolite esebenzayo ye-abiraterone acetate, eyi-acetate yomlomo esebenzayo yomlo we-anabacteriacularone enento yokwenza ne-antiandrogen, esetyenziselwa ukunyanga umhlaza wesifo somqolo wesibeleko.

Ilawulwa njenge-O-acetate, isetyenziselwa ukunyanga umhlaza wesifo somhlaza esimalunga ne-metastatic castrate. Inendima njenge-arhente ye-antineoplastic kunye ne-EC 1.14.99.9 (i-steroid 17alpha-monoo oxygenase) inhibitor. Yi-3beta-sterol kunye nelungu leepyridines. Ivela kwi-hydride ye-androstane.

Imbekiselo:

  • I-1: Grist E, Attard G. Ukuphuhliswa kwe-acetate ye-abiraterone yomhlaza wesifo somhlaza. I-Urol Oncol. I-2015 Jun; 33 (6): 289-294. doi: 10.1016 / j.urolonc.2015.03.021. Uphononongo. I-PubMed PMID: 26025264.
  • I-2: I-Petrelli F, i-Coinu A, iBorgonovo K, iCabiddu M, i-Ghilardi M, iLonati V, uBarni S. Enzalutamide Emva koNyango lwe-Detaeta kunye ne-Abiraterone Acetate kwi-Prostate Cancer: Uhlalutyo lwePokotho ye-10 Case Series. ICancer yeGenitourin Umhlaza. NgoJuni ka-2015; 13 (3): 193–198. doi: 10.1016 / j.clgc.2014.10.006. Epub 2014 Nov 7. Uphononongo. I-PubMed PMID: 25466676.
  • I-3: UGiacinti S, uBassanelli M, u-Aschelter AM, uMilano A, uRoberto M, uMarchetti P. Ukuchasana nomhlaza we-abiraterone kumhlaza wesifo somhlaza wesibeleko: uphononongo loncwadi. Isifo se-Anticancer Res. Ngo-2014 u-Nov; 34 (11): 6265-9. Uphononongo. I-PubMed PMID: 25368223.
  • I-4: I-Zobniw CM, i-Causebrook A, i-Fong MK. Ukusetyenziswa kweklinikhi kwe-abiraterone kunyango lwe-metastatic castration-immune cancer. Ukuphendula kwakhona iUrol. Ngo-2014 Aug 5; 6: 97-105. doi: 10.2147 / RRU.S29003. eCollection 2014. Uphengululo. I-PubMed PMID: 25157341; I-PubMed Central PMCID: PMC4128838.
  • I-5: UFrancini E, uPetrioli R, uRoviello G. Akukho bungqina bucacileyo benzuzo yeklinikhi yonyango olunokulandelelana ngokunyanga nge-abiraterone acetate kunye ne-enzalutamide. Ugqirha Rev Anticancer Ther. Ngo-2014 Oct; 14 (10): 1135-40. doi: 10.1586 / 14737140.2014.949677. Epub 2014 Aug 19. Uphononongo. I-PubMed PMID: 25135334.

ISIQINISEKISO NESIBONELELO:

Le nto ithengiselwe uKwenziwa koPhando kuphela. Imigaqo yokuthengisa Faka isicelo. Ayisetyenziselwa uBuntu, okanye oNyango, iZilwanyana, okanye abaNtu.


IAAA

HNMR

I-10161-33-8 HNMR

Recipes

I-Trenbolone Raw powder Recipes

Ukubuza ummeli wethu ummeli (Representative Representative) (CSR) ngeenkcukacha, ngokubhekiselele kuyo.

Iziqulatho kunye nokuqulunqwa kwemveliso